TGFB1 and pulmonary fibrosis: Substantial evidence indicates that aerobic glycolysis is prevalent in numerous fibrotic conditions, including liver, kidney, heart, lung, and skin fibrosis.[8] Our previous study further demonstrated increased glycolytic activity in lung tissues of mice with silica dust‐induced pulmonary fibrosis and in transforming growth factor‐beta 1 (TGF‐β1)‐induced activated fibroblasts.[9] Like the Warburg effect, glycolysis is essential for providing energy and essential components for ECM synthesis.